# Monitoring Allergen Immunotherapy in Allergic Rhinitis

> **NCT05621356** · — · UNKNOWN · sponsor: **Rijnstate Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Immunotherapy
- Rhinitis, Allergic
- Treatment Outcome

## Interventions

- **OTHER:** A nasal fluid Basophil Activation Test (BAT)

## Key facts

- **NCT ID:** NCT05621356
- **Lead sponsor:** Rijnstate Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-25
- **Primary completion:** 2022-12-23
- **Final completion:** 2023-03-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2022-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05621356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05621356, "Monitoring Allergen Immunotherapy in Allergic Rhinitis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05621356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*